We verified that the percentages of CD3+CD4+ and CD3+CD8+ cells were memorably reduced in the AML model mice relative to the control mice, while this reduction could be signally attenuated by DC-CIK cells. The gene discussed is CD8A; the disease is acute myeloid leukemia.